The present application discloses novel substituted tetrahydro-pyran-4-ylmethyl-pyrimidin derivatives and their use as modulators of the voltage gated KV7 (KCNQ) potassium ion channels. In other aspects the application discloses the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising these compounds.
本申请公开了新型的替代
四氢呋喃-4-基
甲基嘧啶衍
生物,以及它们作为调节电压门控KV7(KCNQ)
钾离子通道的用途。在其他方面,本申请还公开了利用这些化合物进行治疗的方法,以及包含这些化合物的药物组合物。